Nomura Asset Management CO LTD Recursion Pharmaceuticals, Inc. Transaction History
Nomura Asset Management CO LTD
- $31.8 Billion
- Q3 2024
A detailed history of Nomura Asset Management CO LTD transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 56,310 shares of RXRX stock, worth $445,975. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,310
Previous 56,310
-0.0%
Holding current value
$445,975
Previous $422,000
12.09%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RXRX
# of Institutions
302Shares Held
241MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$256 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$197 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$192 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$137 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$122 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.43B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...